AROVESS Trademark

Trademark Overview

On Wednesday, December 16, 2020, a trademark application was filed for AROVESS with the United States Patent and Trademark Office. The USPTO has given the AROVESS trademark a serial number of 90386272. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, October 16, 2023. This trademark is owned by Acceleron Pharma Inc.. The AROVESS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cardiovascular and pulmonary diseases and disorders; pharmaceutical preparations for the treatment of pulmonary hypertension
arovess

General Information

Serial Number90386272
Word MarkAROVESS
Filing DateWednesday, December 16, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, October 16, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 20, 2021

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of cardiovascular and pulmonary diseases and disorders; pharmaceutical preparations for the treatment of pulmonary hypertension

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, February 25, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMERCK SHARP & DOHME LLC
Party Type21 - New Owner After Publication
Legal Entity Type16 - Limited Liability Company
AddressRAHWAY, NJ 07065
Party NameAcceleron Pharma Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139
Party NameAcceleron Pharma Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Trademark Events

Event DateEvent Description
Monday, October 16, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, October 16, 2023ABANDONMENT - NO USE STATEMENT FILED
Tuesday, March 14, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, March 11, 2023SOU EXTENSION 3 GRANTED
Saturday, March 11, 2023SOU EXTENSION 3 FILED
Saturday, March 11, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, October 12, 2022AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, October 5, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 4, 2022SOU EXTENSION 2 GRANTED
Friday, September 9, 2022SOU EXTENSION 2 FILED
Friday, September 23, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, September 9, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, March 8, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, March 4, 2022SOU EXTENSION 1 GRANTED
Friday, March 4, 2022SOU EXTENSION 1 FILED
Friday, March 4, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, March 2, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, March 2, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, March 2, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, March 2, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, March 2, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, September 14, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 20, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 20, 2021PUBLISHED FOR OPPOSITION
Wednesday, June 30, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, June 16, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 9, 2021ASSIGNED TO EXAMINER
Thursday, February 25, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, December 19, 2020NEW APPLICATION ENTERED

Related Keywords

arovess pulmonary pharmaceutical treatment preparations hypertension disorders cardiovascular diseases